Page 31 - Service Testing News Today

By Dean Seal Shares of VistaGen Therapeutics surged in early trading after a Phase 3 study of company's fasedienol nasal spray as a treatment for social...

Despite its strong start to the year, the drugmaker’s report on Tuesday should lift shares even further.

Pill, to be taken daily for two weeks, significantly reduced postpartum depression among new mothers in recent trial

By Chris Wack Spero Therapeutics received written agreement from the U.S. Food and Drug Administration, under a Special Protocol Assessment, on the design...

By Colin Kellaher MyMD Pharmaceuticals shares rose sharply Monday after the clinical-stage pharmaceutical company reported positive results from a Phase 2...

By Elena Vardon Oxford Cannabinoid Technologies Holdings shares rose Thursday after the company said it has administered the first dose of its lead drug...

By Joshua Kirby hVIVO said Wednesday that it is confident of meeting its revenue and profitability goals for the full year, as high demand for its testing...

By Chris Wack Larimar Therapeutics shares were up 10% at $3.44 after the U.S. Food and Drug Administration cleared the company's Phase 2 dose-exploration...

By Josh Beckerman Stoke Therapeutics shares fell to an all-time low after the biotechnology company reported nearly a third of patients in ongoing Phase 1/2a...

By Yifan Wang Shares of Cansino Biologics rose in Hong Kong, as the regulatory approval for the Chinese biotech firm's vaccine gave investors a boost of...